Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Max Yates

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
The Journal of Rheumatology|February 3, 2020
Feasibility and Face Validity of Outcome Measures for Use in Future Studies of Polymyalgia Rheumatica: An OMERACT StudyMax Yates, Claire E Owen, Sara Muller, et al.
RMD Open|September 29, 2017
Validation of the EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis by disease content expertsMax Yates, Richard Watts, Ingeborg Bajema, et al.
Rheumatology (Oxford, England)|April 8, 2025
Executive Summary: The 2025 British Society for Rheumatology guideline for the treatment of axial spondyloarthritis with biologic and targeted synthetic DMARDsSizheng Steven Zhao, Stephanie R Harrison, Ben Thompson, et al.
Rheumatology (Oxford, England)|April 8, 2025
The 2025 British Society for Rheumatology guideline for the treatment of axial spondyloarthritis with biologic and targeted synthetic DMARDsSizheng Steven Zhao, Stephanie R Harrison, Ben Thompson, et al.
Rheumatology (Oxford, England)|January 13, 2023
An international survey of current management practices for polymyalgia rheumatica by general practitioners and rheumatologistsAgnete Overgaard Donskov, Sarah Louise Mackie, Ellen Margrethe Hauge, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
The Journal of Rheumatology|February 3, 2020
Feasibility and Face Validity of Outcome Measures for Use in Future Studies of Polymyalgia Rheumatica: An OMERACT StudyMax Yates, Claire E Owen, Sara Muller, et al.
RMD Open|September 29, 2017
Validation of the EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis by disease content expertsMax Yates, Richard Watts, Ingeborg Bajema, et al.
Rheumatology (Oxford, England)|April 8, 2025
Executive Summary: The 2025 British Society for Rheumatology guideline for the treatment of axial spondyloarthritis with biologic and targeted synthetic DMARDsSizheng Steven Zhao, Stephanie R Harrison, Ben Thompson, et al.
Rheumatology (Oxford, England)|April 8, 2025
The 2025 British Society for Rheumatology guideline for the treatment of axial spondyloarthritis with biologic and targeted synthetic DMARDsSizheng Steven Zhao, Stephanie R Harrison, Ben Thompson, et al.
Rheumatology (Oxford, England)|January 13, 2023
An international survey of current management practices for polymyalgia rheumatica by general practitioners and rheumatologistsAgnete Overgaard Donskov, Sarah Louise Mackie, Ellen Margrethe Hauge, et al.
Pageof 5